Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A hereditary sensory neuropathy characterized by X-linked inheritance of slowly progressing neuropathy with onset in the first or second decade of life.
Features include: Decreased number of peripheral myelinated nerve fibers and Sensory neuropathy.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Sensory neuropathy |
Biomarker and diagnostic research for hereditary sensory neuropathy X-linked has been reported in the published literature.
No clinical trials have been registered for hereditary sensory neuropathy X-linked.
4 publications have been identified in PubMed for hereditary sensory neuropathy X-linked. Research spans Diagnostic / Biomarker (25%), Review / Meta-Analysis (25%), and Case Report / Case Series (25%).
Formaggio F (2025). [PMID: 40516708](https://pubmed.ncbi.nlm.nih.gov/40516708/). *Neurobiology of disease*. [Basic Science / Preclinical]
Mahmood M (2025). [PMID: 40156251](https://pubmed.ncbi.nlm.nih.gov/40156251/). *IUBMB life*. [Review / Meta-Analysis]
Munir A (2025). [PMID: 41253761](https://pubmed.ncbi.nlm.nih.gov/41253761/). *Human genome variation*. [Case Report / Case Series]
Tu S (2024). [PMID: 39112530](https://pubmed.ncbi.nlm.nih.gov/39112530/). *Scientific reports*. [Diagnostic / Biomarker]
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 9:04 PM UTC
Online Mendelian Inheritance in Man
AI-curated news mentioning hereditary sensory neuropathy X-linked
Updated Feb 14, 2026
Recent research identifies mitochondrial energetic failure as a key factor in FLVCR1-related sensory neuropathy. This discovery could pave the way for targeted therapies addressing the underlying mitochondrial dysfunction.